Conneqt Health Limited - Asset Resilience Ratio
Conneqt Health Limited (CQT) has an Asset Resilience Ratio of 0.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Conneqt Health Limited short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Conneqt Health Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Conneqt Health Limited assets under control.
Liquid Assets Composition Over Time
This chart breaks down Conneqt Health Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Conneqt Health Limited (CQT) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Conneqt Health Limited maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Conneqt Health Limited Industry Peers by Asset Resilience Ratio
Compare Conneqt Health Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Conneqt Health Limited (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Conneqt Health Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$9.32 Million ≈ $6.60 Million |
-- |
| 2024-06-30 | 38.50% | AU$4.87 Million ≈ $3.45 Million |
AU$12.65 Million ≈ $8.95 Million |
+0.27pp |
| 2023-06-30 | 38.23% | AU$5.56 Million ≈ $3.93 Million |
AU$14.54 Million ≈ $10.29 Million |
+29.81pp |
| 2022-06-30 | 8.43% | AU$1.04 Million ≈ $738.22K |
AU$12.38 Million ≈ $8.76 Million |
-22.92pp |
| 2021-06-30 | 31.35% | AU$3.53 Million ≈ $2.50 Million |
AU$11.26 Million ≈ $7.97 Million |
-- |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more